Kiniksa Pharmaceuticals International, plc
KNSA
43 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Jun 16 9:23 PM | Tessari Eben | Proposed Sale | 17,300 | $28.28 | $489.2K | — | View → |
| Jun 11, 2025 | Jun 11 8:39 PM | Tessari Eben | Proposed Sale | 45,042 | $30.51 | $1.4M | — | View → |
| Jun 10, 2025 | Jun 10 9:46 PM | Tessari Eben | Proposed Sale | 15,506 | $30.46 | $472.2K | — | View → |
| Jun 9, 2025 | Jun 9 9:09 PM | Tessari Eben | Proposed Sale | 10,319 | $30.38 | $313.5K | — | View → |
| Jun 9, 2025 | Jun 9 9:08 PM | Quart Barry D | Proposed Sale | 27,448 | $30.26 | $830.6K | — | View → |
| Jun 3, 2025 | Jun 3 8:36 PM | Megna Michael R | Proposed Sale | 15,211 | $28.75 | $437.3K | — | View → |
| Jun 3, 2025 | Jun 3 8:35 PM | Moat Ross | Proposed Sale | 27,594 | $29.02 | $800.9K | — | View → |
| Jun 3, 2025 | Jun 3 8:34 PM | Ragosa Mark | Proposed Sale | 18,299 | $28.80 | $527.0K | — | View → |
| May 19, 2025 | May 19 9:16 PM | Tessari Eben | Proposed Sale | 12,000 | $26.41 | $316.9K | — | View → |
| May 7, 2025 | May 7 9:13 PM | Patel Sanj K | Proposed Sale | 99,586 | $27.00 | $2.7M | — | View → |
| May 7, 2025 | May 7 8:59 PM | Paolini John F. | Proposed Sale | 29,525 | $27.00 | $797.2K | — | View → |
| May 7, 2025 | May 7 8:00 PM | Megna Michael R | Proposed Sale | 17,647 | $26.69 | $471.0K | — | View → |
| May 5, 2025 | May 5 8:11 PM | Moat Ross | Proposed Sale | 6,272 | $28.00 | $175.6K | — | View → |
| May 2, 2025 | May 2 9:01 PM | Moat Ross | Proposed Sale | 3,850 | $28.01 | $107.8K | — | View → |
| May 1, 2025 | May 1 9:11 PM | Ragosa Mark | Proposed Sale | 25,141 | $27.80 | $698.9K | — | View → |
| May 1, 2025 | May 1 9:10 PM | Moat Ross | Proposed Sale | 23,234 | $28.02 | $650.9K | — | View → |
| Apr 30, 2025 | Apr 30 8:32 PM | Ragosa Mark | Proposed Sale | 21,254 | $26.95 | $572.8K | — | View → |
| Apr 29, 2025 | Apr 29 8:29 PM | Moat Ross | Proposed Sale | 64,035 | $25.21 | $1.6M | — | View → |
| Apr 29, 2025 | Apr 29 8:29 PM | Ragosa Mark | Proposed Sale | 42,000 | $25.61 | $1.1M | — | View → |
| Apr 21, 2025 | Apr 21 8:06 PM | Moat Ross | Proposed Sale | 18,259 | $20.29 | $370.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Apr 8 8:39 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 2,477 | — | 0(D) | View → |
| Apr 7, 2026 | Apr 8 8:38 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 3,932 | — | 0(D) | View → |
| Apr 6, 2026 | Apr 8 8:34 PM | Barry D QuartDirector | Option Exercise | 6,901 | $14.33 | 26,336(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Option Exercise | 5,975 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Grant/Award | 58,100 | $48.13 | 16,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Grant/Award | 54,550 | $48.13 | 15,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 5,187 | — | 5,536(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 21,327 | — | 25,826(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 210,300 | $48.13 | 60,100(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 5,831 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Grant/Award | 46,850 | $48.13 | 13,400(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Grant/Award | 64,700 | $48.13 | 18,500(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 5,808 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Grant/Award | 25,550 | $48.13 | 7,300(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 7,564 | — | 7,931(D) | View → |
| Mar 9, 2026 | Mar 11 8:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 36,722 | $26.74 | 22,790(D) | View → |
| Mar 2, 2026 | Mar 4 9:40 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 40,000 | $10.36 | 58,424(D) | View → |
| Feb 12, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Option Exercise | 2,690 | $15.47 | 0(D) | View → |
| Feb 10, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Option Exercise | 110 | $15.47 | 2,690(D) | View → |
| Feb 9, 2026 | Feb 11 9:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 10,845 | $16.90 | 0(D) | View → |